Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Oral Oncol. 2012 Jul 20;48(12):1202–1207. doi: 10.1016/j.oraloncology.2012.06.002

Figure 3.

Figure 3

Mouse tumor model of UMSCC-11B show dEGFATFKDEL is effective at inhibiting tumor growth. As seen in (a) tumor growth was inhibited in dEGFATFKDEL treated mice as compared with the no treatment mice. Student t test analysis was performed for dEGFATFKDEL treated tumors compared with untreated tumors on each day. The tumor size between groups became significantly different on day 23 (p<0.05). Body weight was measured in (b) and shows that treated mice did not have any significant weight loss due to drug toxicity throughout the study.